Rajiv Patni

Insider Reports History

Entity
Individual
Location
C/O Ocera Therapeutics, Inc., 525 University Avenue, Suite 610, Palo Alto, CA
Signature
/s/ Javier Rodriguez, Attorney-in-Fact for Rajiv Patni
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rajiv Patni:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BioXcel Therapeutics, Inc. Director Stock Option (right to buy) 44K Jan 15, 2025 Direct
Quince Therapeutics, Inc. Director Employee Stock Option (right to buy) 13.5K Jun 5, 2024 Direct
REATA PHARMACEUTICALS INC EVP, Chief R&D Officer Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC EVP, Chief R&D Officer Employee Stock Option (right to buy) 0 Sep 26, 2023 Direct

Insider Reports Filed by Rajiv Patni

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BTAI BioXcel Therapeutics, Inc. Jan 15, 2025 1 $0 4 Jan 16, 2025 Director
BTAI BioXcel Therapeutics, Inc. Jan 15, 2025 0 $0 3 Jan 16, 2025 Director
QNCX Quince Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
QNCX Quince Therapeutics, Inc. Feb 15, 2024 1 $0 4 Feb 15, 2024 Director
QNCX Quince Therapeutics, Inc. Feb 15, 2024 0 $0 3 Feb 15, 2024 Director
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 2 $0 4 Sep 26, 2023 EVP, Chief R&D Officer
RETA REATA PHARMACEUTICALS INC Jun 12, 2023 2 $0 4 Jun 14, 2023 EVP, Chief R&D Officer
RETA REATA PHARMACEUTICALS INC Jun 12, 2023 0 $0 3 Jun 14, 2023 EVP, Chief R&D Officer